The life sciences industry has undergone dramatic changes and effective global collaboration has become a key success factor in this new age. BIOVIA is providing a hosted and comprehensive solution stack for externalized, collaborative research for pharma/biotech and CROs to address these new challenges. Recently we added the support for biologics data management and IP capture. In this talk we will present collaborative and comprehensive capabilities in antibody characterization and development: capabilities to analyze, annotate and predict developability as part of a framework that facilitates secure data sharing and collaboration.
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...L.E.K. Consulting
L.E.K. Managing Director Alex Vadas spoke at a BDA workshop on "How to Mature Emerging Technologies into Companion Diagnostics?" See his presentation here.
The Laboratory Analytical and Life Science Instrument Industries: Looking Ahe...Bill Kelly
We take a look at the market hotspots to watch in 2018 for the Laboratory Analytical and Life Science Instrument Industries by giving you an overview of the market by the numbers and highlight specific industries including spectroscopy, chromatography, diagnostics, and laboratory software.
Structure-Based Drug Design Facts & Figures InfographicJames Prudhomme
Among 32 pharma and biotech companies surveyed, structure-based drug design is the most prevalent activity with the most players emphasizing the fragment-based variation.
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis
ValGenesis delivered a validated and qualified system in six weeks – the rapid implementation we needed. The system has been stable from the start, with little need for customer support calls, allowing us to focus on training and bringing on new users every week.”
— Steve Johnson, Director, Operations
Injectable Facility
ScinoPharm Taiwan, Ltd.
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...L.E.K. Consulting
L.E.K. Managing Director Alex Vadas spoke at a BDA workshop on "How to Mature Emerging Technologies into Companion Diagnostics?" See his presentation here.
The Laboratory Analytical and Life Science Instrument Industries: Looking Ahe...Bill Kelly
We take a look at the market hotspots to watch in 2018 for the Laboratory Analytical and Life Science Instrument Industries by giving you an overview of the market by the numbers and highlight specific industries including spectroscopy, chromatography, diagnostics, and laboratory software.
Structure-Based Drug Design Facts & Figures InfographicJames Prudhomme
Among 32 pharma and biotech companies surveyed, structure-based drug design is the most prevalent activity with the most players emphasizing the fragment-based variation.
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis
ValGenesis delivered a validated and qualified system in six weeks – the rapid implementation we needed. The system has been stable from the start, with little need for customer support calls, allowing us to focus on training and bringing on new users every week.”
— Steve Johnson, Director, Operations
Injectable Facility
ScinoPharm Taiwan, Ltd.
For Life Sciences, the Future of Master Data Management is in the CloudCognizant
Cloud-based MDM is cost-effective and easily implemented; it is scalable, robust and mature; and it has the flexibility required to enable and support the evolving transformation of life sciences commercial operations.
This Slideshare discusses the current state, technical and workflow challenges, and the future state of Patient Generated Health Data. Learn more: https://accntu.re/2KeGkZ6
PAREXEL's Matt Neal joins experts from Microsoft and Allergan to discuss how innovations in technology can help patients by reducing the time and expense of bringing life-saving treatments to market.
Janice Haigh, PAREXEL's Worldwide Head of Pricing & Market Access, on how clinical research organizations simplify the journey from strategy to results.
Vertex Reduces EDC Study Build Times by 50%Veeva Systems
Watch the video here: https://bit.ly/3oUi6Vg
The clinical data team at Vertex asked themselves, how can we reduce our development timelines and costs—make things go faster, for less?
Answering those questions set Vertex on a path to challenge themselves and their vendors to improve speed without sacrificing quality. As a result, they’re reducing database build times by as much as 50% and reliably lock data in 15-18 days.
This webinar covers:
* How Vertex reaches 80-90% compliance with sites entering data within 2 days of the event
* Their #1 goal for transforming the UAT process
* Their novel recommendation for when to go live
* The technology strategy supporting their process improvements
Who Will Benefit:
* Clinical data executives
* Heads of clinical
* Heads of clinical research
Meet Your Presenters:
Vikas Gulati
Senior Director of Clinical Data Management and Metrics, Vertex Pharmaceuticals
Vikas Gulati has over 20 years’ experience focused on clinical data management, data standards and governance. He has led several global cross-functional teams to successful outcomes in Biotech/Pharma and CROs. He is currently the Global Head of Clinical Data Management at Vertex Pharmaceuticals, Inc.
Richard Young
Vice President, Vault EDC, Veeva Systems
Richard Young has nearly 25 years of expertise in data management, clinical solutions, and advanced clinical strategies. At Veeva, Young is establishing Vault EDC as the leading solution for clinical data management.
Michelle Harrison
Associate Director of Clinical Data Management and Metrics, Vertex
Michelle Harrison is currently working at Vertex Pharmaceutical in Boston Massachusetts as an Associate Director of Data Management. Prior to joining Vertex, she worked as a consultant for BioBridges. For 2 years there she consulted for a number of small Biotechs assisting with Vendor oversight and start up activities.
PICI’s Best Practices for Building Oncology Studies in an EDCVeeva Systems
Watch the video here: https://bit.ly/3vrYslR
The Parker Institute for Cancer Immunotherapy (PICI) runs complex clinical trials that depend on an electronic data capture (EDC) system that is adaptive, flexible and innovating at the same pace as their patient-centric mission.
Learn why their legacy EDC system workarounds and custom functions no longer sustained their business, which motivated them to take a new approach. In this webinar, Toby Odenheim, the Director of Technology and Governance, will share how PICI decided to adopt a new EDC system that streamlines the build process for oncology trials and how they better equip their clinical programmers and data managers. PICI’s lead study builder, Gary Smith, will provide a hands-on perspective and share strategies to handle the key challenges that oncology teams face with EDC systems, including:
* Umbrella trials that evaluate multiple therapies
* Adaptive trial branching and routing
* Having an unknown number of treatment cycles
* Amendments and other unplanned changes
Who Will Benefit:
* Data managers
* Database Programmers
* Clinical Programmers
* Clinical programmers in charge of building studies
* Clinical leaders in charge of selecting EDC systems
* EDC Programmers
Meet Your Presenters:
Toby Odenheim
Director, Technology and Governance, Parker Institute for Cancer Immunotherapy
In his current role as director of technology and governance at PICI, Toby Odenheim, MBA, leads an array of technology and process improvement initiatives aimed at accelerating the development of innovative cancer immunotherapy treatments. Core areas of oversight include management of clinical and pharmacovigilance systems, including CTMS, eTMF, IRT, EDC, ePRO, medical coding, safety, and business intelligence systems.
Prior to joining PICI, Odenheim was the founder and principal at Odin Life Sciences Consulting, where he guided companies in the selection, implementation, and validation of best-of-breed clinical technologies. Toby Odenheim has held management positions at Gilead, Synteract, ClinicalSoft, and Pfizer. He holds an undergraduate degree in biology, an MBA, and professional certifications in finance, Oracle database administration, and relational database design.
Gary Smith
Senior EDC Programmer/Analyst, Parker Institute for Cancer Immunotherapy
Gary has over twenty years of experience in clinical programming and is a subject matter expert on study design, configuration, and testing with off-the-shelf EDC systems including Veeva Vault CDMS, Medidata Rave, and Oracle Clinical. Gary has deep expertise in building oncology studies, specifically platform studies, and is currently responsible for all aspects of EDC design and study builds in immuno-oncology studies with the Parker Institute for Cancer Immunotherapy. Gary has developed global libraries for five different companies, spanning medical device and pharmaceutical industries.
Transforming Pharmacovigilance Workflows with AI & Automation Perficient, Inc.
Medical information call centers have an opportunity to transform the way they capture, code, and analyze adverse events (AEs) and product quality complaints (PQCs) with artificial intelligence (AI) and automation.
The use of such innovative technology improves data quality and consistency, compliance, and operational efficiency. It helps reduce the frequency of your pharmacovigilance (PV) operations resources going home, saying, “I have more to do at the end of the day than I did when I started."
Our one-hour, on-demand webinar shows you how you can use AI and automation to turbo-charge your end-to-end PV system. Use cases and demonstrations will include:
Analyzing safety data
Auto-coding verbatim terms to official medical dictionary terms
Auto-creating an AE case in your database
Converting speech to text
Site Connect — The Next Big Step Toward a Collaborative Clinical EcosystemVeeva Systems
Automating information exchange in clinical trials is key to improving how sponsors, CROs, and sites work together. This webinar shares how Veeva Vault Site Connect seamlessly connects sponsor and site operations for better collaboration and faster study execution.
Hear this webinar on-demand: https://go.veeva.com/collaborative-clinical-ecosystem
Unify quality manufacturing to drive speed, compliance and collaborationVeeva Systems
Whether you are an emerging CDMO looking to scale and attract sponsors or an established generics org looking to transform legacy systems, there is an approach to consider! Learn how you can drive efficiency, collaboration, and compliance and how to get started in unifying your quality manufacturing processes.
GSK: Preparing the Business for Study Start-up ChangeVeeva Systems
At the 2020 Veeva R&D and Quality Summit, GSK detailed their journey to transform study start-up. See their presentation slides for practical advice on gaining stakeholder alignment, issue resolution, and best practices to institute governance around a unified clinical program.
Watch on-demand: https://www.veeva.com/events/rd-summit/presentations/
It’s an expensive und exhausting run against time: It takes approximately 2,3 billion Dollars and 12 years to bring a drug to the market. This leaves only 8 years until the expiration of the patent to bring back sufficient return on investments. So far, this has worked out well for the industry but the run is getting steeper every year: on the one hand, it becomes increasingly complex and expensive to develop new drugs, on the other hand prizes are under scrutiny. Hence, the industry is sitting on a time bomb, as the day will come when the returns will not cover the investments anymore and the innovation pipeline will dry out because bringing new drugs to the market does no longer offer any financial incentives.
What can be done about this scenario? Eventually (and hopefully), these projections prove wrong as there is still a lot to be gained by efficiency improvement through digitalizing all along the value chain – after all healthcare still is one of the least digitalized industries. Will this be enough – or do we have to reinvent healthcare innovation in a radical new way?
This DayOne Experts Event showcased some game changing ideas and discussed their feasibility and impact with an expert panel and the audience. These slides are just the intro to this Event.
FocalCxm presentation on improving productivity in life sciences researchFOCALCXM
This webinar is organized by FocalCXM in partnership with Salesforce. As part of this webinar, we will walk you through our vision and explain how the various aspects of Salesforce and Heroku come to life to improve the overall productivity of research in Life Sciences.
Informatics Platforms for Biologics R&D: 5 Key Capabilities to Look ForRoger Pellegrini
Platforms that are effective for biologics R&D must be built from the ground up to address the unique nature of biologics. Learn the five critical capabilities to look for when evaluating an informatics platform for biologics R&D.
For Life Sciences, the Future of Master Data Management is in the CloudCognizant
Cloud-based MDM is cost-effective and easily implemented; it is scalable, robust and mature; and it has the flexibility required to enable and support the evolving transformation of life sciences commercial operations.
This Slideshare discusses the current state, technical and workflow challenges, and the future state of Patient Generated Health Data. Learn more: https://accntu.re/2KeGkZ6
PAREXEL's Matt Neal joins experts from Microsoft and Allergan to discuss how innovations in technology can help patients by reducing the time and expense of bringing life-saving treatments to market.
Janice Haigh, PAREXEL's Worldwide Head of Pricing & Market Access, on how clinical research organizations simplify the journey from strategy to results.
Vertex Reduces EDC Study Build Times by 50%Veeva Systems
Watch the video here: https://bit.ly/3oUi6Vg
The clinical data team at Vertex asked themselves, how can we reduce our development timelines and costs—make things go faster, for less?
Answering those questions set Vertex on a path to challenge themselves and their vendors to improve speed without sacrificing quality. As a result, they’re reducing database build times by as much as 50% and reliably lock data in 15-18 days.
This webinar covers:
* How Vertex reaches 80-90% compliance with sites entering data within 2 days of the event
* Their #1 goal for transforming the UAT process
* Their novel recommendation for when to go live
* The technology strategy supporting their process improvements
Who Will Benefit:
* Clinical data executives
* Heads of clinical
* Heads of clinical research
Meet Your Presenters:
Vikas Gulati
Senior Director of Clinical Data Management and Metrics, Vertex Pharmaceuticals
Vikas Gulati has over 20 years’ experience focused on clinical data management, data standards and governance. He has led several global cross-functional teams to successful outcomes in Biotech/Pharma and CROs. He is currently the Global Head of Clinical Data Management at Vertex Pharmaceuticals, Inc.
Richard Young
Vice President, Vault EDC, Veeva Systems
Richard Young has nearly 25 years of expertise in data management, clinical solutions, and advanced clinical strategies. At Veeva, Young is establishing Vault EDC as the leading solution for clinical data management.
Michelle Harrison
Associate Director of Clinical Data Management and Metrics, Vertex
Michelle Harrison is currently working at Vertex Pharmaceutical in Boston Massachusetts as an Associate Director of Data Management. Prior to joining Vertex, she worked as a consultant for BioBridges. For 2 years there she consulted for a number of small Biotechs assisting with Vendor oversight and start up activities.
PICI’s Best Practices for Building Oncology Studies in an EDCVeeva Systems
Watch the video here: https://bit.ly/3vrYslR
The Parker Institute for Cancer Immunotherapy (PICI) runs complex clinical trials that depend on an electronic data capture (EDC) system that is adaptive, flexible and innovating at the same pace as their patient-centric mission.
Learn why their legacy EDC system workarounds and custom functions no longer sustained their business, which motivated them to take a new approach. In this webinar, Toby Odenheim, the Director of Technology and Governance, will share how PICI decided to adopt a new EDC system that streamlines the build process for oncology trials and how they better equip their clinical programmers and data managers. PICI’s lead study builder, Gary Smith, will provide a hands-on perspective and share strategies to handle the key challenges that oncology teams face with EDC systems, including:
* Umbrella trials that evaluate multiple therapies
* Adaptive trial branching and routing
* Having an unknown number of treatment cycles
* Amendments and other unplanned changes
Who Will Benefit:
* Data managers
* Database Programmers
* Clinical Programmers
* Clinical programmers in charge of building studies
* Clinical leaders in charge of selecting EDC systems
* EDC Programmers
Meet Your Presenters:
Toby Odenheim
Director, Technology and Governance, Parker Institute for Cancer Immunotherapy
In his current role as director of technology and governance at PICI, Toby Odenheim, MBA, leads an array of technology and process improvement initiatives aimed at accelerating the development of innovative cancer immunotherapy treatments. Core areas of oversight include management of clinical and pharmacovigilance systems, including CTMS, eTMF, IRT, EDC, ePRO, medical coding, safety, and business intelligence systems.
Prior to joining PICI, Odenheim was the founder and principal at Odin Life Sciences Consulting, where he guided companies in the selection, implementation, and validation of best-of-breed clinical technologies. Toby Odenheim has held management positions at Gilead, Synteract, ClinicalSoft, and Pfizer. He holds an undergraduate degree in biology, an MBA, and professional certifications in finance, Oracle database administration, and relational database design.
Gary Smith
Senior EDC Programmer/Analyst, Parker Institute for Cancer Immunotherapy
Gary has over twenty years of experience in clinical programming and is a subject matter expert on study design, configuration, and testing with off-the-shelf EDC systems including Veeva Vault CDMS, Medidata Rave, and Oracle Clinical. Gary has deep expertise in building oncology studies, specifically platform studies, and is currently responsible for all aspects of EDC design and study builds in immuno-oncology studies with the Parker Institute for Cancer Immunotherapy. Gary has developed global libraries for five different companies, spanning medical device and pharmaceutical industries.
Transforming Pharmacovigilance Workflows with AI & Automation Perficient, Inc.
Medical information call centers have an opportunity to transform the way they capture, code, and analyze adverse events (AEs) and product quality complaints (PQCs) with artificial intelligence (AI) and automation.
The use of such innovative technology improves data quality and consistency, compliance, and operational efficiency. It helps reduce the frequency of your pharmacovigilance (PV) operations resources going home, saying, “I have more to do at the end of the day than I did when I started."
Our one-hour, on-demand webinar shows you how you can use AI and automation to turbo-charge your end-to-end PV system. Use cases and demonstrations will include:
Analyzing safety data
Auto-coding verbatim terms to official medical dictionary terms
Auto-creating an AE case in your database
Converting speech to text
Site Connect — The Next Big Step Toward a Collaborative Clinical EcosystemVeeva Systems
Automating information exchange in clinical trials is key to improving how sponsors, CROs, and sites work together. This webinar shares how Veeva Vault Site Connect seamlessly connects sponsor and site operations for better collaboration and faster study execution.
Hear this webinar on-demand: https://go.veeva.com/collaborative-clinical-ecosystem
Unify quality manufacturing to drive speed, compliance and collaborationVeeva Systems
Whether you are an emerging CDMO looking to scale and attract sponsors or an established generics org looking to transform legacy systems, there is an approach to consider! Learn how you can drive efficiency, collaboration, and compliance and how to get started in unifying your quality manufacturing processes.
GSK: Preparing the Business for Study Start-up ChangeVeeva Systems
At the 2020 Veeva R&D and Quality Summit, GSK detailed their journey to transform study start-up. See their presentation slides for practical advice on gaining stakeholder alignment, issue resolution, and best practices to institute governance around a unified clinical program.
Watch on-demand: https://www.veeva.com/events/rd-summit/presentations/
It’s an expensive und exhausting run against time: It takes approximately 2,3 billion Dollars and 12 years to bring a drug to the market. This leaves only 8 years until the expiration of the patent to bring back sufficient return on investments. So far, this has worked out well for the industry but the run is getting steeper every year: on the one hand, it becomes increasingly complex and expensive to develop new drugs, on the other hand prizes are under scrutiny. Hence, the industry is sitting on a time bomb, as the day will come when the returns will not cover the investments anymore and the innovation pipeline will dry out because bringing new drugs to the market does no longer offer any financial incentives.
What can be done about this scenario? Eventually (and hopefully), these projections prove wrong as there is still a lot to be gained by efficiency improvement through digitalizing all along the value chain – after all healthcare still is one of the least digitalized industries. Will this be enough – or do we have to reinvent healthcare innovation in a radical new way?
This DayOne Experts Event showcased some game changing ideas and discussed their feasibility and impact with an expert panel and the audience. These slides are just the intro to this Event.
FocalCxm presentation on improving productivity in life sciences researchFOCALCXM
This webinar is organized by FocalCXM in partnership with Salesforce. As part of this webinar, we will walk you through our vision and explain how the various aspects of Salesforce and Heroku come to life to improve the overall productivity of research in Life Sciences.
Informatics Platforms for Biologics R&D: 5 Key Capabilities to Look ForRoger Pellegrini
Platforms that are effective for biologics R&D must be built from the ground up to address the unique nature of biologics. Learn the five critical capabilities to look for when evaluating an informatics platform for biologics R&D.
Access the webinar: http://goo.gl/p08pTz
These slides were presented in a webinar by Denodo in collaboration with BioStorage Technologies and Indiana Clinical and Translational Sciences Institute and Regenstrief Institute.
BioStorage Technologies, Inc., Indiana Clinical and Translational Sciences Institute, and Regenstrief Institute (CTSI) have joined Denodo to talk about the important role of technological advancements, such as data virtualization, in advancing biospecimen research.
By watching this webinar, you can gain insight into best practices around the integration of biospecimen and research data as well as technology solutions that provide consolidated views and rapid conversions of this data into valuable business insights. You will also learn how data virtualization can assist with the integration of data residing in heterogeneous repositories and can securely deliver aggregated data in real-time.
tranSMART Community Meeting 5-7 Nov 13 - Session 5: Recent tranSMART Lessons ...David Peyruc
tranSMART Community Meeting 5-7 Nov 13 - Session 5: Recent tranSMART Lessons Learned in Academic and Life Science Settings
Dan Housman, Recombinant by Deloitte
The Recombinant by Deloitte team has worked with organizations such as Kimmel Cancer Center as a model to adapt existing mature i2b2 implementations to meet business and scientific needs. Other organizations are increasingly focused on how to use cloud and high performance computing models to achieve different performance levels. Advanced initiatives are progressing to link commercial tools such as Qlikview to explore tranSMART data and to solve for key gaps in scientific pipelines. Dan will present recent lessons learned, new capabilities, and some of the impact on the path forwards for future tranSMART updates.
According to Deloitte, approximately 50% of biotech/pharma collaborations will fail, part of what leads to that failure is ambiguity in communication. "Where did this result come from?", "What was the protocol used in this experiment?", "What does this value represent?"
At Aspen Biosciences, our Pipeline platform makes it easy for drug discovery companies, CROs, and pharmas to collaborate and share data seamlessly, using a common, industry-standard vocabulary.
Considerations and challenges in building an end to-end microbiome workflowEagle Genomics
Many of the data management and analysis challenges in microbiome research are shared with genomics and other life-science big-data disciplines. However there are aspects that are specific: some are intrinsic to microbiome data, some are related to the maturity of the field, with others related to extracting business value from the data.
IRIDA: A Federated Bioinformatics Platform Enabling Richer Genomic Epidemiolo...William Hsiao
Introducing BCCDC and Public Health Microbiology (PHM)
Current State of PHM
Sequence Technology Advancement -> revolution of PHM
Genomic Epidemiology
Amount of Sequence Data Produced
Need to Process the data – Introduction to IRIDA
Need of Metadata and Ontology
Software to improve data sharing
How research microbiology and PHM can joint effort
The current paradigm in the pharmaceutical industry is that products can only be created and developed by massive collaborative teams. Each company has to build their own costly R&D platforms and IT infrastructure. Other research industries realized decades ago that they had to share data and methods because of cost. The pharmaceutical industry has been slow to realize this. Expanding beyond our recent book (Collaborative Computational Technologies for Biomedical Research) in which a growing number of technologies, consortia, precompetitive initiatives and complex collaboration networks are described, we suggest a more open drug discovery is being enabled by collaborative computational technologies. Academia however, is not training the next generation of scientists to practice open science or even collaborate, this represents challenges and opportunities. We will describe our observations and make recommendations that impact everyone from technology developers to granting agencies. This may enable future discoveries to be made outside traditional institutions.
Enterprise systems in healthcare: leveraging what we know from other industr...CONFENIS 2012
Dr. Carol Brown - distinguished professor at Stevens Institute of Technology , The Howe School of Technology Management
enterprise systems in healthcare: leveraging what we know from other industries
Pharma Research Automation by Connecting Researchers with Robots and Systems ...camunda services GmbH
The discovery of new therapeutic molecule has become a highly demanding endeavour. The main goal is to find an effective molecule, i.e. one that address a particular disease. On this path many conditions need to be met. A critical one is to ensure the safety of the molecule, meaning that it only targets the disease and nothing more. Next, while having ensured safety and effectiveness, another question that arises is the suitability for production, i.e. is it even possible to produce the molecule consistently and at scale over the many years the medicine will be available on the market? This is especially challenging for biologics, i.e. large therapeutic molecules produced by living cells.
Looking at the software landscape in pharma research we are confronted with a highly heterogeneous view, involving a broad combinations of different software systems with various interfacing possibilities. Molecules are tracked in registration systems, lab information management systems or electronic lab notebooks store process data. Requests between labs are handled by requesting systems, robotic systems (liquid handlers, analytics) produce large data and we can’t ignore the amount of spreadsheets used to document or calculate.
While faced with complex questions, researchers have developed a series of individual methods that, on their own, answer or help with a small part of the questions above. The true value comes by automating the combination of these methods into end-to-end processes that answer the full research question. Thus it is more than fitting to use business process modelling not only to describe the research process, but to also execute it.
In this presentation we show the use of business process modelling to map and drive research processes stretching over researcher decision points, backend systems and robots. In particular, our current robot integration is to treat robots as external systems where the orchestration engine configures, monitors and collects results while the user is still fully in charge of loading and triggering an actual run. Unlike fully automated setups, a research environment demands flexibility as processes and their branches change. Even so, we show by using executable business processes in the pharma industry research, we increase throughput, transparency, standardization and time-to-results .
Curlew Research Brussels 2014 Electronic Data & Knowledge ManagementNick Lynch
Life Science externalisation and collaboration overview and the challenges that Life Science companies face in delivering successful data sharing with their partners in either Open Innovation or pre-competitive workflows
Similar to ScienceCloud: Collaborative Workflows in Biologics R&D (20)
(ATS6-PLAT09) Deploying Applications on load balanced AEP servers for high av...BIOVIA
Enterprise web applications and web services require a highly available and scalable environment. During this session, we’ll demonstrate how Accelrys Enterprise Platform 9 is deployed and configured within a load-balanced environment.
(ATS6-PLAT07) Managing AEP in an enterprise environmentBIOVIA
Accelrys Enterprise Platform use within an Enterprise environment spans from Power users of Pipeline Pilot to web applications and High Performance Computing. Managing the balance between productivity and enterprise policies can be tricky. This session will focus on exposing the tools and processes needed by administrators to enable users to be productive, yet allowing IT to remain in control.
How to get the maximum performance from your AEP server. This will discuss ways to improve execution time of short running jobs and how to properly configure the server depending on the expected number of users as well as the average size and duration of individual jobs. Included will be examples of making use of job pooling, Database connection sharing, and parallel subprotocol tuning. Determining when to make use of cluster, grid, or load balanced configurations along with memory and CPU sizing guidelines will also be discussed.
(ATS6-PLAT05) Security enhancements in AEP 9BIOVIA
In the latest version of the Accelrys Enterprise Platform we have streamlined how permissions are managed and added the capability for packages to define groups and permission sets. In addition, enhancements have been made to File Based Authentication, we have added support for enterprise authentication solutions like Kerberos and SAML and improved the usability of the Administration Portal. This session describes the new features and how to manage them through the Administration Portal.
The Query Service is the new platform solution for querying a variety of data sources. The goal of Query Service is that administrators can configure a metadata description of the data source that can then be used by end users without detailed knowledge of the underlying data source. This session explains how to configure Query Service data sources and use them with the RESTful API or component collection.
(ATS6-PLAT02) Accelrys Catalog and Protocol ValidationBIOVIA
Accelrys Catalog is a powerful new technology for creating an index of the protocols and components within your organization. You will learn about strategies for indexing and how search capabilities can be deployed to professional client and Web Port end users. You will also learn how to use this technology to find out about system usage to aid with system upgrades, server consolidations, and general system maintenance. The protocol validation capability in the admin portal allows administrators to created standard reports on server usage characteristics. You will learn how to report on violations of IT policies (e.g. around security), bad protocol authoring practices, or missing or incomplete protocol documentation. Developers will also learn how to extend and customize the rules used to create these reports.
(ATS6-PLAT01) Chemistry Harmonization: Bringing together the Direct 9 and Pip...BIOVIA
Pipeline Pilot Chemistry 9.0 is inheriting many new chemical representations from the Accelrys Direct data model. These include the support of the Self Contained Sequence Representation (SCSR) biologics, enhanced Markush structure representations, Markush homology groups, and Non Specific Structures (NONS). Also significantly enhanced is the support for Sgroups, in particular for polymers, mixtures, and formulations. Further, Pipeline Pilot depiction has been upgraded to support these enhancements and the stereochemical perception and ring perception capabilities were improved based on Direct.
The major benefit of these changes is that Direct and Pipeline Pilot now use the same data model. Searches carried out in Direct or in Pipeline Pilot will return identical results and both products will deliver identical structural perceptions. This session will give guidance on how these changes will impact your calculators and models and how you can plan for a smooth upgrade.
(ATS6-GS04) Performance Analysis of Accelrys Enterprise Platform 9.0 on IBM’s...BIOVIA
IBM recently completed a benchmarking study of several key modules of the Accelrys Enterprise Platform (AEP) 9.0, using IBM’s iDataPlex and General Parallel File System (GPFS). The results show that the performance of IO intensive workloads, such as Next Generation Sequencing (NGS), can be improved significantly by using GPFS. NGS workloads can also benefit from better load balancing implemented on AEP 9.0. Best practices for scalable IT solutions will also be discussed.
In this session, we will look at how the Accelrys Enterprise Platform facilitates the integration between Contur and HEOS to implement compound registration form Contur into HEOS without leaving the Contur experiment.
This general session will introduce you to Accelrys Tech Summit (ATS6). The welcome overview will discuss what the audience can expect during the Tech Summit as well as how Accelrys plans on following up with some of the key discussion points and topics, and will inform the audience on how they can best leverage the tracks, sessions, and Accelrys employees to make the most of their time.
The Introduction to Scientific Innovation Lifecycle Management will provide the audience with context when attending the different technical sessions on how our solutions and technologies fit together to uniquely address the challenges faced by our customers worldwide and in different industries.
(ATS6-DEV09) Deep Dive into REST and SOAP Integration for Protocol AuthorsBIOVIA
Pipeline Pilot has always had a strong focus on integration to external resources. In AEP 9.0 we continue this tradition with a major overhaul of our SOAP Connector component as well as improved support for RESTful services. In this talk we will look at how to build protocols that access SOAP services especially secured services and review the approach to accessing RESTful services.
(ATS6-DEV08) Integrating Contur ELN with other systems using a RESTful APIBIOVIA
In order to enable easy integration between Contur ELN and other informatics systems a RESTful API has been developed. Data may be extracted from ELN experiments using GET calls, but external applications can also insert results directly into the ELN record. In particular the API can be used with Accelrys Enterprise Platform to create complex flows for resolving scientific problems. Such protocols may be launched from within the ELN client.
(ATS6-DEV07) Building widgets for ELN home pageBIOVIA
From a developer’s perspective, the Accelrys ELN Home Page is a container of widgets. It manages the layout of widgets, and handles the persistence of their settings. Several widgets are provided with the application: one for creating new experiments, another for tracking work in progress, and an inbox widget for messages sent through the notebook. This out-of-the-box set can be supplemented by building custom widgets.
This session will show several custom widgets examples to demonstrate the basic concepts of widget development and the API they implement. We will also discuss best practices, and how to make your widget a good citizen of the Home Page.
(ATS6-DEV06) Using Packages for Protocol, Component, and Application DeliveryBIOVIA
Delivering protocols, components, and applications to users and other developers on an AEP server can be very challenging. Accelrys delivers the majority of its AEP services in the form of packages. This talk will discuss the methods that anyone can use to deliver bundled applications in the form of packages and the benefits of doing so. The discussion will include how to create packages, modifying existing packages, deploying packages to servers, and tools that can be used for ensuring the quality of the packages.
(ATS6-DEV05) Building Interactive Web Applications with the Reporting CollectionBIOVIA
The reporting component collection in AEP provides powerful tools for building user interfaces for web applications, while leveraging the breadth of functionality of AEP for data querying and manipulation. This session will explore some of the tools available for creating web applications using the reporting collection.
(ATS6-DEV04) Building Web MashUp applications that include Accelrys Applicati...BIOVIA
One of the biggest challenges in most corporate environments is providing a way for users to access all the data they need, usually stored in multiple disparate locations, from one interface that they are comfortable with. As web applications have become more popular, RESTful APIs have emerged as the preffered web service format in recent years. Many Accelrys applications now provide RESTful APIs that allow developers to build mashup applications. This session will explore some of these APIs and how to use them to build a simple application.
(ATS6-DEV03) Building an Enterprise Web Solution with AEPBIOVIA
In this session, we'll take a deep dive into building an Enterprise Solution with AEP. We'll be using Pipeline Pilot to develop the protocols that will provide our server-side implementations and ExtJS to build the user interface. We'll look at the techniques involved in using protocols to implement actions and explore the capabilities of ExtJS to produce powerful enterprise applications.
AEP provides a range of options for developing web applications. Understanding these options, their strengths and the decision making process involved in choosing the right strategy is key to leveraging the power of the platform and ensuring you achieve your goals and do so on schedule. From simple reporting protocols developed exclusively using Pipeline Pilot through to Rich Internet Applications built using JavaScript and ExtJS, we'll take a look at the work involved, required skillsets and time considerations to ensure you make the right choice for your project.
(ATS6-DEV01) What’s new for Protocol and Component Developers in AEP 9.0BIOVIA
This will focus on new features that are now available to protocol and component developers in the new version of AEP. This will include discussions of improvements to hierarchical data records and XML reading and writing, new parameter subprotocol promotion behavior, new component icons, parameter metadata, easier to access Job Pooling settings, Pilotscript updates, Hashmap improvements, Unicode reading improvements, and other improvements to protocol development.
In 2015, I used to write extensions for Joomla, WordPress, phpBB3, etc and I ...Juraj Vysvader
In 2015, I used to write extensions for Joomla, WordPress, phpBB3, etc and I didn't get rich from it but it did have 63K downloads (powered possible tens of thousands of websites).
Why React Native as a Strategic Advantage for Startup Innovation.pdfayushiqss
Do you know that React Native is being increasingly adopted by startups as well as big companies in the mobile app development industry? Big names like Facebook, Instagram, and Pinterest have already integrated this robust open-source framework.
In fact, according to a report by Statista, the number of React Native developers has been steadily increasing over the years, reaching an estimated 1.9 million by the end of 2024. This means that the demand for this framework in the job market has been growing making it a valuable skill.
But what makes React Native so popular for mobile application development? It offers excellent cross-platform capabilities among other benefits. This way, with React Native, developers can write code once and run it on both iOS and Android devices thus saving time and resources leading to shorter development cycles hence faster time-to-market for your app.
Let’s take the example of a startup, which wanted to release their app on both iOS and Android at once. Through the use of React Native they managed to create an app and bring it into the market within a very short period. This helped them gain an advantage over their competitors because they had access to a large user base who were able to generate revenue quickly for them.
SOCRadar Research Team: Latest Activities of IntelBrokerSOCRadar
The European Union Agency for Law Enforcement Cooperation (Europol) has suffered an alleged data breach after a notorious threat actor claimed to have exfiltrated data from its systems. Infamous data leaker IntelBroker posted on the even more infamous BreachForums hacking forum, saying that Europol suffered a data breach this month.
The alleged breach affected Europol agencies CCSE, EC3, Europol Platform for Experts, Law Enforcement Forum, and SIRIUS. Infiltration of these entities can disrupt ongoing investigations and compromise sensitive intelligence shared among international law enforcement agencies.
However, this is neither the first nor the last activity of IntekBroker. We have compiled for you what happened in the last few days. To track such hacker activities on dark web sources like hacker forums, private Telegram channels, and other hidden platforms where cyber threats often originate, you can check SOCRadar’s Dark Web News.
Stay Informed on Threat Actors’ Activity on the Dark Web with SOCRadar!
Advanced Flow Concepts Every Developer Should KnowPeter Caitens
Tim Combridge from Sensible Giraffe and Salesforce Ben presents some important tips that all developers should know when dealing with Flows in Salesforce.
How Recreation Management Software Can Streamline Your Operations.pptxwottaspaceseo
Recreation management software streamlines operations by automating key tasks such as scheduling, registration, and payment processing, reducing manual workload and errors. It provides centralized management of facilities, classes, and events, ensuring efficient resource allocation and facility usage. The software offers user-friendly online portals for easy access to bookings and program information, enhancing customer experience. Real-time reporting and data analytics deliver insights into attendance and preferences, aiding in strategic decision-making. Additionally, effective communication tools keep participants and staff informed with timely updates. Overall, recreation management software enhances efficiency, improves service delivery, and boosts customer satisfaction.
Innovating Inference - Remote Triggering of Large Language Models on HPC Clus...Globus
Large Language Models (LLMs) are currently the center of attention in the tech world, particularly for their potential to advance research. In this presentation, we'll explore a straightforward and effective method for quickly initiating inference runs on supercomputers using the vLLM tool with Globus Compute, specifically on the Polaris system at ALCF. We'll begin by briefly discussing the popularity and applications of LLMs in various fields. Following this, we will introduce the vLLM tool, and explain how it integrates with Globus Compute to efficiently manage LLM operations on Polaris. Attendees will learn the practical aspects of setting up and remotely triggering LLMs from local machines, focusing on ease of use and efficiency. This talk is ideal for researchers and practitioners looking to leverage the power of LLMs in their work, offering a clear guide to harnessing supercomputing resources for quick and effective LLM inference.
A Comprehensive Look at Generative AI in Retail App Testing.pdfkalichargn70th171
Traditional software testing methods are being challenged in retail, where customer expectations and technological advancements continually shape the landscape. Enter generative AI—a transformative subset of artificial intelligence technologies poised to revolutionize software testing.
Prosigns: Transforming Business with Tailored Technology SolutionsProsigns
Unlocking Business Potential: Tailored Technology Solutions by Prosigns
Discover how Prosigns, a leading technology solutions provider, partners with businesses to drive innovation and success. Our presentation showcases our comprehensive range of services, including custom software development, web and mobile app development, AI & ML solutions, blockchain integration, DevOps services, and Microsoft Dynamics 365 support.
Custom Software Development: Prosigns specializes in creating bespoke software solutions that cater to your unique business needs. Our team of experts works closely with you to understand your requirements and deliver tailor-made software that enhances efficiency and drives growth.
Web and Mobile App Development: From responsive websites to intuitive mobile applications, Prosigns develops cutting-edge solutions that engage users and deliver seamless experiences across devices.
AI & ML Solutions: Harnessing the power of Artificial Intelligence and Machine Learning, Prosigns provides smart solutions that automate processes, provide valuable insights, and drive informed decision-making.
Blockchain Integration: Prosigns offers comprehensive blockchain solutions, including development, integration, and consulting services, enabling businesses to leverage blockchain technology for enhanced security, transparency, and efficiency.
DevOps Services: Prosigns' DevOps services streamline development and operations processes, ensuring faster and more reliable software delivery through automation and continuous integration.
Microsoft Dynamics 365 Support: Prosigns provides comprehensive support and maintenance services for Microsoft Dynamics 365, ensuring your system is always up-to-date, secure, and running smoothly.
Learn how our collaborative approach and dedication to excellence help businesses achieve their goals and stay ahead in today's digital landscape. From concept to deployment, Prosigns is your trusted partner for transforming ideas into reality and unlocking the full potential of your business.
Join us on a journey of innovation and growth. Let's partner for success with Prosigns.
Strategies for Successful Data Migration Tools.pptxvarshanayak241
Data migration is a complex but essential task for organizations aiming to modernize their IT infrastructure and leverage new technologies. By understanding common challenges and implementing these strategies, businesses can achieve a successful migration with minimal disruption. Data Migration Tool like Ask On Data play a pivotal role in this journey, offering features that streamline the process, ensure data integrity, and maintain security. With the right approach and tools, organizations can turn the challenge of data migration into an opportunity for growth and innovation.
First Steps with Globus Compute Multi-User EndpointsGlobus
In this presentation we will share our experiences around getting started with the Globus Compute multi-user endpoint. Working with the Pharmacology group at the University of Auckland, we have previously written an application using Globus Compute that can offload computationally expensive steps in the researcher's workflows, which they wish to manage from their familiar Windows environments, onto the NeSI (New Zealand eScience Infrastructure) cluster. Some of the challenges we have encountered were that each researcher had to set up and manage their own single-user globus compute endpoint and that the workloads had varying resource requirements (CPUs, memory and wall time) between different runs. We hope that the multi-user endpoint will help to address these challenges and share an update on our progress here.
Gamify Your Mind; The Secret Sauce to Delivering Success, Continuously Improv...Shahin Sheidaei
Games are powerful teaching tools, fostering hands-on engagement and fun. But they require careful consideration to succeed. Join me to explore factors in running and selecting games, ensuring they serve as effective teaching tools. Learn to maintain focus on learning objectives while playing, and how to measure the ROI of gaming in education. Discover strategies for pitching gaming to leadership. This session offers insights, tips, and examples for coaches, team leads, and enterprise leaders seeking to teach from simple to complex concepts.
Your Digital Assistant.
Making complex approach simple. Straightforward process saves time. No more waiting to connect with people that matter to you. Safety first is not a cliché - Securely protect information in cloud storage to prevent any third party from accessing data.
Would you rather make your visitors feel burdened by making them wait? Or choose VizMan for a stress-free experience? VizMan is an automated visitor management system that works for any industries not limited to factories, societies, government institutes, and warehouses. A new age contactless way of logging information of visitors, employees, packages, and vehicles. VizMan is a digital logbook so it deters unnecessary use of paper or space since there is no requirement of bundles of registers that is left to collect dust in a corner of a room. Visitor’s essential details, helps in scheduling meetings for visitors and employees, and assists in supervising the attendance of the employees. With VizMan, visitors don’t need to wait for hours in long queues. VizMan handles visitors with the value they deserve because we know time is important to you.
Feasible Features
One Subscription, Four Modules – Admin, Employee, Receptionist, and Gatekeeper ensures confidentiality and prevents data from being manipulated
User Friendly – can be easily used on Android, iOS, and Web Interface
Multiple Accessibility – Log in through any device from any place at any time
One app for all industries – a Visitor Management System that works for any organisation.
Stress-free Sign-up
Visitor is registered and checked-in by the Receptionist
Host gets a notification, where they opt to Approve the meeting
Host notifies the Receptionist of the end of the meeting
Visitor is checked-out by the Receptionist
Host enters notes and remarks of the meeting
Customizable Components
Scheduling Meetings – Host can invite visitors for meetings and also approve, reject and reschedule meetings
Single/Bulk invites – Invitations can be sent individually to a visitor or collectively to many visitors
VIP Visitors – Additional security of data for VIP visitors to avoid misuse of information
Courier Management – Keeps a check on deliveries like commodities being delivered in and out of establishments
Alerts & Notifications – Get notified on SMS, email, and application
Parking Management – Manage availability of parking space
Individual log-in – Every user has their own log-in id
Visitor/Meeting Analytics – Evaluate notes and remarks of the meeting stored in the system
Visitor Management System is a secure and user friendly database manager that records, filters, tracks the visitors to your organization.
"Secure Your Premises with VizMan (VMS) – Get It Now"
Globus Compute wth IRI Workflows - GlobusWorld 2024Globus
As part of the DOE Integrated Research Infrastructure (IRI) program, NERSC at Lawrence Berkeley National Lab and ALCF at Argonne National Lab are working closely with General Atomics on accelerating the computing requirements of the DIII-D experiment. As part of the work the team is investigating ways to speedup the time to solution for many different parts of the DIII-D workflow including how they run jobs on HPC systems. One of these routes is looking at Globus Compute as a way to replace the current method for managing tasks and we describe a brief proof of concept showing how Globus Compute could help to schedule jobs and be a tool to connect compute at different facilities.
Field Employee Tracking System| MiTrack App| Best Employee Tracking Solution|...informapgpstrackings
Keep tabs on your field staff effortlessly with Informap Technology Centre LLC. Real-time tracking, task assignment, and smart features for efficient management. Request a live demo today!
For more details, visit us : https://informapuae.com/field-staff-tracking/
Unleash Unlimited Potential with One-Time Purchase
BoxLang is more than just a language; it's a community. By choosing a Visionary License, you're not just investing in your success, you're actively contributing to the ongoing development and support of BoxLang.
Cyaniclab : Software Development Agency Portfolio.pdfCyanic lab
CyanicLab, an offshore custom software development company based in Sweden,India, Finland, is your go-to partner for startup development and innovative web design solutions. Our expert team specializes in crafting cutting-edge software tailored to meet the unique needs of startups and established enterprises alike. From conceptualization to execution, we offer comprehensive services including web and mobile app development, UI/UX design, and ongoing software maintenance. Ready to elevate your business? Contact CyanicLab today and let us propel your vision to success with our top-notch IT solutions.
Accelerate Enterprise Software Engineering with PlatformlessWSO2
Key takeaways:
Challenges of building platforms and the benefits of platformless.
Key principles of platformless, including API-first, cloud-native middleware, platform engineering, and developer experience.
How Choreo enables the platformless experience.
How key concepts like application architecture, domain-driven design, zero trust, and cell-based architecture are inherently a part of Choreo.
Demo of an end-to-end app built and deployed on Choreo.
top nidhi software solution freedownloadvrstrong314
This presentation emphasizes the importance of data security and legal compliance for Nidhi companies in India. It highlights how online Nidhi software solutions, like Vector Nidhi Software, offer advanced features tailored to these needs. Key aspects include encryption, access controls, and audit trails to ensure data security. The software complies with regulatory guidelines from the MCA and RBI and adheres to Nidhi Rules, 2014. With customizable, user-friendly interfaces and real-time features, these Nidhi software solutions enhance efficiency, support growth, and provide exceptional member services. The presentation concludes with contact information for further inquiries.
3. Industry Trends
• Number of new drugs
approved per billion US
dollars spent on R&D has
halved roughly every 9 years
since 1950
• Average cost of bringing a
new drug to market: $2.6B*
Nature Reviews Drug Discovery 11, 191-200 (March 2012)
* ‘Cost to Develop and Win Marketing Approval for a New Drug’
Joseph A. DiMasi, director of economic analysis at Tufts CSDD, 2014
5. External Collaboration Challenges
• Internal IT infrastructure not suitable for external projects
• Work is manual and error prone
• Starting up / closing down projects can take months
• Every collaboration is different / not clear where to go
6. ScienceCloud
• A suite of cloud-based integrated apps able to interface with on-prem systems to
support networked scientific workflows for all shapes of external collaborations
A
AA
Transfer,
Translate,
Transform
A
Data
Documents
Context
Integrated Apps
API
Social Mobile Security IntegrationAdmin
Business rules Tech transfer Automation
8. Challenges in Biologics Discovery
Innovation Barriers
• Lack of dedicated tools to:
• process and understand high volume
antibody sequence data, assay data
and cell line data together
• assess developability early in the
process
• rapidly customize workflows
• Integrate, process and report on
data through all phases of the
discovery process
• Lack of real time project tracking and
collaboration with internal and external
partners
• Lack of biologically aware and
integrated:
• registration system
• sample and assay management systems
• ELN and corporate databases
• bioprocess systems
• process optimization systems
• regulatory quality and compliance systems
Process Efficiency Barriers
9. BIOVIA Suite for Antibody R&D
Antibody
R&D
Analysis
Biotherapeutics
Workbench (BTx) Predictive
Analytics
Discovery
Studio
Custom
Workflows
Pipeline Pilot
Entity
Mgmt
Registration
and Sample
Laboratory
Management
ELN & EKB
Process
Knowledge
Discoverant
Innovation
Barriers
Process
Efficiency
Barriers
10. External Collaboration with Biologics
Notebook
Registration
1. Receive biologic (antigen) from
supplier
2. Register biologic
3. Share with external partner
4. Request synthesis of hybridoma
clones
4. Synthesize biologic
5. Document experiment in
ScienceCloud Notebook
6. Send notification to pharma
7. Pick up synthesized clones
8. Merge with assay data
9. Analyze in BTX workbench (annotate cluster)
10. Share and report
BTX
Workbench
22. Wrap Up
• Effective external collaboration is key
success factor
• Biologics functionality has matured and
now available both on-prem and in the
cloud
• ton.vandaelen@3ds.com
23. Contact Info
• Visit us on the web at www.sciencecloud.com
• Find us on LinkedIn:
• Join the ScienceCloud LinkedIn Group: ScienceCloud: Transforming Externalized
Drug Discovery
• Follow the BIOVIA page
• To get in touch with a ScienceCloud team member, please click here
Editor's Notes
I want to start out by stating a fact that I am sure you are well too aware of. the number of new drugs approved per billion dollars spent on R&D has halved roughly every 9 years since 1950. The cost of getting a drug to market is growing the curve here is adjusted for inflation and appears to be the opposite of the graphs we are used to seeing representing Moores law depicting the dramatic increase in the computer processing power,.
Here’s just a quick overview of the Product Life Cycle for Discovery, Dev and manufacturing of biologics,
Informatics needs are highlighted by t the arrows below. Today we are only going to talk about value we add in the biologics discovery space but keep in mind that the whole is much greater than the sum of its parts. and
There are innovation barriers that include a lack of dedicated tools to:
process and understand high volume antibody sequence data
manage high volumes of sequence data, cell line data,
analyse sequence annotation and activity data together
assess developability early in the process
rapidly customize workflows
These barriers slow speed to market and cost organizations 100’S OF Millions of dollars for each year a drug is not on the market $30Mdollars a day (humira)
There are also process efficiency barriers that include:
a lack of real time project tracking and collaboration with various groups involved in the process
a lack of biologically aware and integrated:
Registration, sample management and bioprocess management systems
Lab management ELN’s and corporate dB’s
if you could:
improve scientific insight and decision-making on promotion of biologic candidates
reduce experiments performed, attributable to easy access to modeling and previous experimental data
reduce time spent recording information for bioprocess experiments
save time assembling relevant information for biologics portfolio review
reduce effort required for technology transfer from research to development
optimize bioprocess and manufacturing
and easily maintain and process compliance documents for regulatory agencies.
(This is the elevator pitch)
If you are developing biologics and are faced with barriers to innovation and barriers to process efficiency we have a solution suite that can save you time and reduce cost associated with errors or lack of accessible information early in the process.
The BIOVIA suite for biologics will allow you to:
capture and render all relationships and structural information for novel biologics
manage and mine all experimental, sample, and results data from bioprocess and cell line management processesintegrate predictive modeling, characterization, and assay information for tracking the progress of your biologics portfolio
And facilitate team decision making and collaboration with:
project-level sharing of data, analysis results and reporting
project-tracking dashboards
And cloud and SaaS-based deployment options
Business Issues in externalization:
How can each participant in the project share the data they have generated with the sponsoring company and where appropriate between the partners in real time?
How can each partners IP be tracked and ownership maintained?
How can dynamic collaborations be spun up and down as needed to support a fast changing project landscape?
What do I do when my internal IT systems can’t address these issues?
Accelrys ScienceCloud addresses these issues, will cover in the next few slides. At a high level, ScienceCloud provides a platform for Information exchange, technology transfer, collaborative workspace, and hosted scientific data
Initial vision is a suite of integrated applications which network of RD partners can use for collaborations, to facilitate better sharing and exchange of data and information
This sharing takes place between “Applications” and partners.
Many apps will still reside on prem, so we have capability to link on prem to cloud…internal and external sources are connected
ScienceCloud Project Data is central collaboration core, applications surround it.
This slide is a complete vision- through releases of a variety of applications, Accelrys ScienceCloud helps customers achieve this vision all at once, or a bit at a time.